TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25888343

Group type: EXPERIMENTAL
Intervention: Structured individual counseling session by a pharmacist in addition to written orientations
Number of subjects: 380

Group type: COMPARATOR
Intervention: Written information about the disease
Number of subjects: 380
Study: 24144900

Group type: EXPERIMENTAL
Intervention: Site nurse-initiated adherence and symptom support telephone calls
Number of subjects: 333

Group type: COMPARATOR
Intervention: Standard of care (no additional calls)
Number of subjects: 333
Study: 21861419

Group type: EXPERIMENTAL
Intervention: Intravenous fentanyl (0.5 microg x kg(‐1) x hr(‐1))
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine (0.4‐0.7 microg x kg(‐1) x hr(‐1) decreased to 0.2‐0.7 microg x kg(‐1) x hr(‐1))
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no continuous intravenous analgesia)
Number of subjects: 45
Study: 19623196

Group type: EXPERIMENTAL
Intervention: Psyllium treatment for 2 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dietary measures alone (Control group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (G1 and G2)
Number of subjects: 40
Study: 17173009

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate eye drops
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 68
Study: 15613142

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 0
Study: 12397274

Group type: EXPERIMENTAL
Intervention: Warm water irrigation
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control (room temperature water)
Number of subjects: 69
Study: 10188743

Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) meal
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low Glycemic Index (LGI) meal
Number of subjects: 8
Study: 8534294

Group type: EXPERIMENTAL
Intervention: Bioscrew (bioabsorbable interference screw)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Metal screw (metal interference screw)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Bioscrew
Number of subjects: 110

Group type: COMPARATOR
Intervention: Metal screw
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Bioscrew and Metal screw
Number of subjects: 110
Study: 2196143

Group type: EXPERIMENTAL
Intervention: olestra (18 gm/day for 28 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 28
Study: 319120

Group type: EXPERIMENTAL
Intervention: Nomifensin, 75 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Viloxazine, 150 mg/day
Number of subjects: 40
Study: 31127757

Group type: EXPERIMENTAL
Intervention: Resistive jaw opening exercise (RJOE) using a portable device
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo group performing RJOE using a sham device with fewer loads
Number of subjects: 40
Study: 31308269

Group type: EXPERIMENTAL
Intervention: Ridge augmentation using non‐resorbable ePTFE membrane only
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ridge augmentation using ePTFE and tenting screw with bone graft Bio‐Oss mixed with autogenous bone particles
Number of subjects: 150

Group type: COMPARATOR
Intervention: Ridge augmentation with a bone block
Number of subjects: 150
Study: 28450193

Group type: EXPERIMENTAL
Intervention: Daily prednisone
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Daily deflazacort
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intermittent prednisone (10 days on/10 days off)
Number of subjects: 300
Study: 24898537

Group type: EXPERIMENTAL
Intervention: Odanacatib 50mg weekly (ODN)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 214
Study: 23497156

Group type: EXPERIMENTAL
Intervention: 6-month intervention program including individual counseling and group sessions
Number of subjects: 1983

Group type: COMPARATOR
Intervention: Control group (1,040 participants)
Number of subjects: 1983
Study: 22036245

Group type: EXPERIMENTAL
Intervention: Glimepiride/metformin 1/500 mg SR
Number of subjects: 33

Group type: COMPARATOR
Intervention: Glimepiride/metformin 2/500 mg SR
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 33
Study: 17658628

Group type: EXPERIMENTAL
Intervention: Acetyl L-carnitine (ALC)
Number of subjects: 96
Study: 16425133

Group type: EXPERIMENTAL
Intervention: Treatment of H. pylori infection plus iron supplementation for 6 weeks
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (iron supplementation only)
Number of subjects: 219
Study: 12868803

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 56000

Group type: COMPARATOR
Intervention: Dose-dense chemotherapy
Number of subjects: 56000

Group type: COMPARATOR
Intervention: Docetaxel (substituted for fluorouracil in combination with doxorubicin and cyclophosphamide)
Number of subjects: 56000
Study: 10950898

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg bd
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Salmeterol 100 microg bd
Number of subjects: 45

Group type: COMPARATOR
Intervention: Salbutamol 200 microg qds
Number of subjects: 45
Study: 8624320

Group type: COMPARATOR
Intervention: No biopsy
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Central biopsy
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Peripheral biopsy
Number of subjects: 161
Study: 1471549

Group type: EXPERIMENTAL
Intervention: Non-effervescent Antabuse tablets (400 mg DSF after overnight fast)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Effervescent Antabuse tablets (800 mg DSF after a light standardized meal)
Number of subjects: 30
Study: 6235082

Group type: EXPERIMENTAL
Intervention: Zimelidine
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 27
Study: 31397255

Group type: COMPARATOR
Intervention: High-Definition Transcranial Direct Current Stimulation (HD-tDCS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Intermittent Theta Burst Stimulation (iTBS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Prolonged Continuous Theta Burst Stimulation (ProcTBS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Divided attention task
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Working memory maintenance task
Number of subjects: 22
Study: 30265045

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy-Trauma (IPT-T)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Clinic Psychotherapy (CP)
Number of subjects: 162
Study: 26885819

Group type: EXPERIMENTAL
Intervention: Amyloid PET imaging (florbetapir PET scanning)
Number of subjects: 278
Study: 25173484

Group type: EXPERIMENTAL
Intervention: MVA.HIVA vaccine
Number of subjects: 73

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 73
Study: 22300892

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous administration of 12 million units (MU) IFN‐α2b daily with ribavirin (1,000‐1,600 mg) for 48 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous administration of 9 MU IFN‐α2b daily with ribavirin (1,000‐1,600 mg) for 48 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous administration of 6 MU IFN‐α2b daily with ribavirin (1,000‐1,600 mg) for 48 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous administration of IFN‐α2b with ribavirin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous administration of IFN‐α2b
Number of subjects: 30
Study: 20554319

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 20211

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20211
Study: 18523583

Group type: EXPERIMENTAL
Intervention: 4 KKW exercise training (4 kcal/kg/week)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: 8 KKW exercise training (8 kcal/kg/week)
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: 12 KKW exercise training (12 kcal/kg/week)
Number of subjects: 373

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 373
Study: 16011678

Group type: EXPERIMENTAL
Intervention: Maximum likelihood estimator (MLE) for treatment assignment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MLE for normal outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Data from a trial comparing two antipsychotics
Number of subjects: 0
Study: 12131074

Group type: EXPERIMENTAL
Intervention: Quality control measures including feedback on terminal digit preference
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active treatment groups
Number of subjects: 0
Study: 10360857

Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 60
Study: 7573997

Group type: EXPERIMENTAL
Intervention: Ephedrine infusion to increase systolic blood pressure by 20%
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 1
Study: 1659173

Group type: EXPERIMENTAL
Intervention: Radiation Therapy (RT) only
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Radiation Therapy + Chemotherapy (RT + Chemo)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Radiation Therapy + Chemotherapy + Misonidazole (RT + Chemo/Miso)
Number of subjects: 149
Study: 6803911

Group type: EXPERIMENTAL
Intervention: Pepsi-Cola
Number of subjects: 10

Group type: COMPARATOR
Intervention: Soda water
Number of subjects: 10

Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study: 31567485

Group type: EXPERIMENTAL
Intervention: Persons with Parkinson's disease
Number of subjects: 100

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 100
Study: 28783867

Group type: EXPERIMENTAL
Intervention: Intravaginal ring (IVR) releasing 1050 μg ATZ per day and 40 μg LNG per day with 400 mg miconazole administered on 3 consecutive evenings during treatment on days 9-11.
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravaginal ring (IVR) releasing 1050 μg ATZ per day and 40 μg LNG per day with 100 mg clindamycin administered on 3 consecutive evenings during treatment on days 9-11.
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravaginal ring (IVR) releasing 1050 μg ATZ per day and 40 μg LNG per day with 75 mg nonoxynol-9 administered on 3 consecutive evenings during treatment on days 9-11.
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravaginal ring (IVR) releasing 1050 μg ATZ per day and 40 μg LNG per day with tampon co-usage performed on days 20-23.
Number of subjects: 52
Study: 27314120

Group type: EXPERIMENTAL
Intervention: Fixed-on-2 (FO2) implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fixed-on-3 (FO3) implants
Number of subjects: 40
Study: 25906603

Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya (SK)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prana-Yoga (PY)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 22678323

Group type: EXPERIMENTAL
Intervention: Gasless video-assisted unilateral anterior chest wall approach
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 77
Study: 20430504

Group type: EXPERIMENTAL
Intervention: Single noncompression miniplate fixed at the superior border of the mandible (Group I)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Two noncompression miniplates (one at the superior border and one at the lateral aspect of the mandible) (Group II)
Number of subjects: 54
Study: 17608932

Group type: EXPERIMENTAL
Intervention: Intensive follow-up (comprehensive assessment visits at baseline and two, four and six months post randomisation)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Minimal follow-up (abbreviated assessment at baseline and full assessment at six months)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Carer quality of life
Number of subjects: 176
Study: 15824055

Group type: EXPERIMENTAL
Intervention: Peer coaching sessions with educational resources for GPs and patients
Number of subjects: 277
Study: 11993095

Group type: EXPERIMENTAL
Intervention: Factor AF2 (500 mg i.v., given at days 0‐3, 7‐10 and 11‐14)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (without Factor AF2)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Both groups (with and without Factor AF2)
Number of subjects: 106
Study: 10220741

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) therapy
Number of subjects: 180
Study: 7532708

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor, 10 micrograms/kg intravenously, administered within 24 hours of birth and at 24-hour intervals for a maximum of three doses if neutropenia persisted
Number of subjects: 9
Study: 2214101

Group type: EXPERIMENTAL
Intervention: Coffee (275 mg of caffeine)
Number of subjects: 22
Study: 110211

Group type: EXPERIMENTAL
Intervention: Bubble oxygenator
Number of subjects: 16

Group type: COMPARATOR
Intervention: Membrane oxygenator
Number of subjects: 16

Group type: COMPARATOR
Intervention: Parenteral nutrition
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Postoperative day 14
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Postoperative day 7
Number of subjects: 16
Study: 31438535

Group type: EXPERIMENTAL
Intervention: BA-ALKplaBCAA&TCM
Number of subjects: 31

Group type: COMPARATOR
Intervention: ALK-BAplaBCAA&TCM
Number of subjects: 31
Study: 27328681

Group type: EXPERIMENTAL
Intervention: Galactose (60g in 500mL water)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Glucose (60g in 500mL water)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fructose (60g in 500mL water)
Number of subjects: 9
Study: 26727778

Group type: EXPERIMENTAL
Intervention: Extended release of posterior knee clearance during total knee arthroplasty
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (clearance of osteophyte in the posterior condyle)
Number of subjects: 120
Study: 24098692

Group type: EXPERIMENTAL
Intervention: Oral contraceptive pills (OCPs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Condoms only
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injectable
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intrauterine device (IUD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contraceptive implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tubal ligation
Number of subjects: 0
Study: 22340793

Group type: EXPERIMENTAL
Intervention: Negative-pressure therapy from -19 kPa to -8 kPa, n = 10
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Negative-pressure therapy, n = 10
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (covered with petrolatum gauze overlaid with saline gauze and dry gauze), n = 10
Number of subjects: 20
Study: 19341912

Group type: EXPERIMENTAL
Intervention: PolyHeme (hemoglobin-based oxygen carrier)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (stored red blood cells)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PolyHeme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (blood)
Number of subjects: 0
Study: 17099388

Group type: EXPERIMENTAL
Intervention: comfilcon A lens
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: lotrafilcon A lens
Number of subjects: 20

Group type: COMPARATOR
Intervention: no lens (control)
Number of subjects: 20
Study: 15651517

Group type: EXPERIMENTAL
Intervention: Sufentanil 5 ug
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Morphine 3 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal saline 20 cc (placebo)
Number of subjects: 45
Study: 17953074

Group type: EXPERIMENTAL
Intervention: Knowledge of gerontological nursing
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Demographic characteristics and education
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Living with elders in family
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Educational background
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Continuing education needs
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Continuing education model
Number of subjects: 130
Study: 10965244

Group type: EXPERIMENTAL
Intervention: 5.5-mm Acrysof lens implants through 3.2-mm outer and 4-mm inner temporal clear corneal openings (stretch incision)
Number of subjects: 147

Group type: COMPARATOR
Intervention: 5-mm PMMA lenses through temporal clear corneal incisions of 4.1-mm outer and 6.5-mm inner diameter incisions
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: 5.5-mm Acrysof lens implants
Number of subjects: 147

Group type: COMPARATOR
Intervention: 5-mm PMMA lenses
Number of subjects: 147
Study: 8986972

Group type: EXPERIMENTAL
Intervention: Continuous infusion of fentanyl (C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bolus dosing of fentanyl (B)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Continuous infusion of fentanyl (C) in phase 2
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bolus dosing of fentanyl (B) in phase 2
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both C and B
Number of subjects: 36
Study: 1618662

Group type: EXPERIMENTAL
Intervention: CT/RT (three cycles of cis‐platinum and 5‐FU chemotherapy followed by postoperative radiotherapy)
Number of subjects: 442

Group type: COMPARATOR
Intervention: RT (postoperative radiotherapy alone)
Number of subjects: 442

Group type: EXPERIMENTAL
Intervention: CT/RT
Number of subjects: 442

Group type: COMPARATOR
Intervention: RT
Number of subjects: 442
Study: 6208728

Group type: EXPERIMENTAL
Intervention: Anesthetic cream with an eutectic mixture of 5% lidocaine and 5% prilocaine applied for 5-15 min.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anesthetic cream with an eutectic mixture of 5% lidocaine and 5% prilocaine applied for 30-60 min.
Number of subjects: 0
Study: 30929015

Group type: EXPERIMENTAL
Intervention: LCARES intervention group (culturally linguistically targeted Spanish-language fotonovela booklet and DVD plus FIT)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Comparison group (non-targeted standard Spanish-language booklet plus FIT)
Number of subjects: 76
Study: 29624523

Group type: EXPERIMENTAL
Intervention: PP-based intervention with booster sessions
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: PP-based intervention with motivational interviewing
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Weekly PP exercises
Number of subjects: 128
Study: 26639986

Group type: EXPERIMENTAL
Intervention: Local Infiltration Analgesia (LIA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Continuous Femoral Nerve Block (FNB)
Number of subjects: 45
Study: 25058250

Group type: EXPERIMENTAL
Intervention: Negative pleural suction (Group 1)
Number of subjects: 110

Group type: COMPARATOR
Intervention: No suction (Group 2)
Number of subjects: 110
Study: 23041996

Group type: EXPERIMENTAL
Intervention: Group A (CAD/CAM system A)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Group B (CAD/CAM system B)
Number of subjects: 10
Study: 19832866

Group type: EXPERIMENTAL
Intervention: Fissurectomy combined with Botulinum Toxin A (80 U of Dysport)
Number of subjects: 21
Study: 17686672

Group type: EXPERIMENTAL
Intervention: Natural interferon treatment for further 16‐36 weeks (mean 23.7 weeks) after pegylated interferon + ribavirin treatment cessation.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Pegylated interferon + ribavirin treatment (before cessation).
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Natural interferon treatment.
Number of subjects: 15
Study: 15716195

Group type: EXPERIMENTAL
Intervention: HAL flexible cystoscopy
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: HAL rigid cystoscopy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard flexible cystoscopy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard white light rigid cystoscopy
Number of subjects: 45
Study: 12079730

Group type: EXPERIMENTAL
Intervention: Bupropion SR (300 mg/day)
Number of subjects: 32
Study: 9534512

Group type: EXPERIMENTAL
Intervention: Ultrasonic toothbrush
Number of subjects: 12
Study: 8553816

Group type: EXPERIMENTAL
Intervention: Hook pins
Number of subjects: 222

Group type: COMPARATOR
Intervention: Sliding screw plate
Number of subjects: 222
Study: 2234803

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no adjuvants)
Number of subjects: 0
Study: 31796467

Group type: EXPERIMENTAL
Intervention: Novel screening program for gastric cancer using serologic tests of Helicobacter pylori antibodies and pepsinogens, and positive family history of gastric cancer in first‐degree relatives (FDR).
Number of subjects: 7773

Group type: EXPERIMENTAL
Intervention: Novel screening program for gastric cancer.
Number of subjects: 7773
Study: 31073737

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo (5% glucose solution)
Number of subjects: 111
Study: 29284453

Group type: EXPERIMENTAL
Intervention: ST segment analysis (STan) monitoring as an adjunct to cardiotocography (CTG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cardiotocography (CTG) alone
Number of subjects: 0
Study: 26024297

Group type: EXPERIMENTAL
Intervention: Blueberry smoothie (twice daily for six weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo smoothie (twice daily for six weeks)
Number of subjects: 44
Study: 24114614

Group type: EXPERIMENTAL
Intervention: Stranger Safety DVD (The Safe Side, 2004) and parent training of abduction-prevention skills
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In situ training from parents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention mentioned)
Number of subjects: 0
Study: 22260080

Group type: EXPERIMENTAL
Intervention: Adenoidectomy with tonsil ablation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Adenoidectomy with partial tonsillectomy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70
Study: 19308718

Group type: EXPERIMENTAL
Intervention: HIV uninfected women
Number of subjects: 1686

Group type: COMPARATOR
Intervention: HIV infected women
Number of subjects: 1686

Group type: EXPERIMENTAL
Intervention: Overall pregnancy rate
Number of subjects: 1686
Study: 16891677

Group type: EXPERIMENTAL
Intervention: Compact fluorescent lamp (CFL) phototherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard-length tube lights (STL) phototherapy
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CFL phototherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: STL phototherapy
Number of subjects: 100